Sclerosis multiplex (SM): vizsgálatok itt: Japán

1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  Where

  Higashi-Matsuyama, Kodaira, Kōriyama, Kyoto, Sapporo, Tokyo, Yahaba

  Életkor

  18 év to 60 év

  People

  160 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07325292 · EU 2026-525688-41-00